Drawing for FROM DISCOVERY TO CURE

USPTO serial 79115014

FROM DISCOVERY TO CURE

Reviewed by CopyMark Law Group

Reg. 4366418Status 706Registered
Filing date
Status date
Registration date
Jul 16, 2013
Examiner
TWOHIG, SHANNON MARIE
Law office
TMO LAW OFFICE 121

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with FROM DISCOVERY TO CURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patricia A. Walker

Patricia A. Walker Walker & Jocke Co., LPA231 South BroadwayMEDINA, OH 44256-2601UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humansACTIVE—
041Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and related medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular childrenACTIVE—
042Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular childrenACTIVE—
044Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counselingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 12, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 12, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
May 11, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
May 11, 202471AGREGISTERED-SEC.71 ACCEPTED—
Mar 25, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 30, 2023CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Sep 16, 2023CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 9, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 14, 2023ES71TEAS SECTION 71 RECEIVED—
Nov 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 16, 2022REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jan 20, 2022RNWLINTERNATIONAL REGISTRATION RENEWED—
Apr 23, 2021NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Apr 23, 2021C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 21, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 20, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 20, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 20, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 20, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 20, 2020EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Dec 28, 2019PR75POST REGISTRATION ACTION MAILED - SEC. 71 & 15—
Nov 1, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 3, 2019ES75TEAS SECTION 71 & 15 RECEIVED—
Dec 27, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 21, 2018NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 13, 2014FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 25, 2014FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 25, 2014FIMPFINAL DISPOSITION PROCESSED—
Oct 16, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 16, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2013GPNXNOTIFICATION PROCESSED BY IB—
Apr 30, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 10, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 10, 2013NPUBNOTICE OF PUBLICATION—
Mar 22, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 18, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 18, 2013CNEAEXAMINERS AMENDMENT MAILED—
Mar 15, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 13, 2013ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 10, 2013PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Feb 25, 2013PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 24, 2013ALIEASSIGNED TO LIE—
Feb 13, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2013CNEAEXAMINERS AMENDMENT MAILED—
Feb 12, 2013XAECEXAMINER'S AMENDMENT ENTERED—
Feb 12, 2013CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 6, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 6, 2013TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 30, 2012RFNTREFUSAL PROCESSED BY IB—
Aug 8, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 8, 2012RFRRREFUSAL PROCESSED BY MPU—
Aug 8, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 7, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2012MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 3, 2012DOCKASSIGNED TO EXAMINER—
Aug 3, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 2, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance